Pharma
4 Unintended Consequences of Seroquel's Adjunct to Antidepressants Indication
Continue reading:
"4 Unintended Consequences of Seroquel's Adjunct to Antidepressants Indication" ››
Are All Drug Reps Hot?
Continue reading:
"Are All Drug Reps Hot?" ››
A Case Study On Why Policy Changes Fail: Pharma Paying Docs
Continue reading:
"A Case Study On Why Policy Changes Fail: Pharma Paying Docs" ››
Why Do Doctors Accept Gifts, And What Would Happen If They Didn't?
Continue reading:
"Why Do Doctors Accept Gifts, And What Would Happen If They Didn't?" ››
Fanapt: Deconstructing A Promotional Slide Deck
Continue reading:
"Fanapt: Deconstructing A Promotional Slide Deck" ››
Most Prescribed Drugs 2009: Post 1, JFK to SFO
Continue reading:
"Most Prescribed Drugs 2009: Post 1, JFK to SFO" ››
Swallow This: How Seroquel XR Works, Part 3
Continue reading:
"Swallow This: How Seroquel XR Works, Part 3" ››
Is More Regulation Needed?
Continue reading:
"Is More Regulation Needed?" ››
Radio Host Has Drug Company Ties
Continue reading:
"Radio Host Has Drug Company Ties " ››
The Supreme Court Hears Arguments That Warning Labels Should Include Things Done Correctly
Continue reading:
"The Supreme Court Hears Arguments That Warning Labels Should Include Things Done Correctly" ››
The Process of Bringing New Drugs To Market
An interview with Alan J. Milbauer, a retired vice president from AstraZeneca and partly responsible for Seroquel, about what goes into the process we're all angry about.
Continue reading:
"The Process of Bringing New Drugs To Market" ››
Undue Influence On Psychiatrists, Or The Public?
This is an example of why the controversy over Pharma influence on doctors is, while accurate, likely irrelevant.
Continue reading:
"Undue Influence On Psychiatrists, Or The Public?" ››
Doctors May Only Be Paid Once
The ACCME (the people who run CMEs) are asking doctors to comment on their proposal, which is:
Persons paid to create, or present, promotional materialson behalf of commercial interests cannot control the content of accredited continuing medical education on that same content.In other words, if you're a doctor that is on Abbott's speaker's bureau for Depakote, you would not be allowed to present CME lectures on Depakote's use in bipolar, because even though CMEs are technically free of Pharma influence, you may have a bias because of your prior financial entanglements.
How could anyone be against this proposal?
Here goes...
Continue reading:
"Doctors May Only Be Paid Once" ››
A Solution To The Pharma Problem
The problem so far is all arguments against Pharma (prices too high; no interest in making meds people need; no interest in cures, only maintenance treatments, etc, etc) fail because they are ethical arguments.
The problem and solution require our reluctant acceptance that the problem is an economic one, and only economics will solve it.
Continue reading:
"A Solution To The Pharma Problem" ››
What Happens If Pharmaceutical Marketing Disappears? Part 1
Everyone (including me) thinks Pharma is too heavily involved with the practice of medicine. So we try to think of ways to stop this. Restrict gifts and consultant fees to doctors; decrease, or at least separate, industry funding from research; and, of course, no more reps in doctors' offices.
These all sound like great ideas, how could you even come up with an argument against any of them?
Here goes.
As a bonus, I even offer a practical long term solution.
Continue reading:
"What Happens If Pharmaceutical Marketing Disappears? Part 1" ››
Drug Reps From Congress To Detail Doctors
Oh, my God, I hope you're lying down for this.
Continue reading:
"Drug Reps From Congress To Detail Doctors" ››
Academics Hide Drug Company Payments
And with good reason.
Continue reading:
"Academics Hide Drug Company Payments" ››
For more articles check out the Archives Web page ››